Department of Gynaecology and Obstetrics, Cangzhou Central Hospital, Cangzhou, China.
Cangzhou Medical College, Cangzhou, China.
J Clin Hypertens (Greenwich). 2018 Feb;20(2):394-399. doi: 10.1111/jch.13161. Epub 2018 Jan 6.
Hypertensive disorders complicating pregnancy can be classified as gestational hypertension, mild preeclampsia, and severe preeclampsia. It is necessary to evaluate and predict the grade in advance. The first study comprised 40 healthy pregnancies, 40 gestational hypertension, 40 mild preeclampsia, and 40 severe preeclampsia cases. The participants' lipid profile and cytokine levels were statistically compared. The efficacy and safety of oral nifedipine (n = 71) and intravenous labetalol (n = 72) for the treatment of severe preeclampsia were evaluated in the next study according to maternal and neonatal outcomes. The levels of lipid profile and cytokines were linked with the presence and severity of hypertensive disorders complicating pregnancy. Both oral nifedipine and intravenous labetalol are effective for safely reducing blood pressure to target levels in patients with severe preeclampsia. Our study suggests that lipid profile and cytokines can be used in the evaluation of the severity of hypertensive disorders complicating pregnancy, and oral nifedipine requires more study.
妊娠合并高血压疾病可分为妊娠期高血压、轻度子痫前期和重度子痫前期。有必要提前进行评估和预测分级。第一项研究纳入了 40 例健康妊娠、40 例妊娠期高血压、40 例轻度子痫前期和 40 例重度子痫前期患者。对患者的血脂谱和细胞因子水平进行了统计学比较。第二项研究根据母婴结局评估了硝苯地平口服(n=71)和拉贝洛尔静脉(n=72)治疗重度子痫前期的疗效和安全性。血脂谱和细胞因子水平与妊娠合并高血压疾病的存在和严重程度有关。硝苯地平口服和拉贝洛尔静脉均能有效、安全地将重度子痫前期患者的血压降至目标水平。我们的研究表明,血脂谱和细胞因子可用于评估妊娠合并高血压疾病的严重程度,硝苯地平口服需要进一步研究。